Saturday, October 31, 2026

°

Bambusa IPO Brings In $169M to Break Immunology’s ‘Therapeutic Ceiling’

Posted Friday, October 30, 2026 1:13 pm

Frank Vinluan (via MedCity News)

Bambusa Therapeutics’ IPO cash will support its pipeline of bispecific antibodies designed to offer advantages over currently available monoclonal antibodies. Aspen Neuroscience also debuted on the Nasdaq as it prepares for a pivotal test of its Parkinson’s disease cell therapy. The post Bambusa IPO Brings In $169M to Break Immunology’s ‘Therapeutic Ceiling’ appeared first on MedCity News.

Continue reading at MedCity News »

Keywords

BioPharma, Pharma, Aspen Neuroscience, atopic dermatitis, Bambusa Therapeutics, biotech IPO, bispecific antibodies, cell therapy, Clinical Trials, immunology, inflammation, Parkinson's Disease

Top stories

Why Women Should Find Out Their Breast Cancer Risk Earlier than You Think

(NewsUSA) - For many people, breast cancer screening becomes a priority around age 40. However, according to recommendations from the American College of Radiology® (ACR®), one of the most …

Ask About Clinical Trials on Day One

(Mitch Jelniker) - For people diagnosed with small cell lung cancer, the clinical trial conversation belongs in the very first appointment.A diagnosis of SCLC can trigger a whirlwind of appointments, …

From Uncertainty to Reassurance: How a Small Heart Monitor and Ablation Procedure Helped One Father Conquer the Unknowns of Atrial Fibrillation

(NewsUSA) - In 2018, then-52-year-old Todd Repass Jr. stood up after a meal and immediately knew something was wrong. It was terrifying. He felt weak, short of breath, and, at times, dizzy. The …

Youth Tobacco Use Is at Historic Lows. Adult Smokers Still Need Better Choices.

(Dr. Matthew Holman) - There is a piece of good public health news that deserves more attention: youth tobacco use in the United States has fallen to historically low levels. That progress did not …

America’s New Drug Dealers Have Moved from Street Corners to the Internet – and the FDA is Letting Them

(Peter Pitts, President and Co-founder of the Center for Medicine in the Public Interest ) - Consumers purchasing retatrutide online may think they are buying a safe, clinically tested weight-loss …

From the web

Caring for aging parents is getting more expensive

By Anna Claire Vollers Stateline Costs are soaring for people who care for their older parents and other family members, according to a new study. Out-of-pocket expenses are nearly 60% higher …

DBT Skills: Managing Big Emotions

When children experience big emotions, our first instinct is often to try to make things better. But what if the most meaningful action we can take is help them feel understood? In this episode of …

InvestorNewsBreaks – Market Street Capital Inc. Brings Capital Markets Expertise to Healthcare Financing

Market Street was featured in an article that highlights its capital markets and financial advisory services for middle-market healthcare companies navigating reimbursement uncertainty, industry …

RockBreaks – Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Strengthens Portfolio with Emergent Metals Acquisition

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising. Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) was featured in a recent article that discussed …

Employer, Pharmacy Advocates Applaud DOL Final Rule on PBMs

The Department of Labor finalized a rule that seeks to bring more transparency into PBM compensation. The post Employer, Pharmacy Advocates Applaud DOL Final Rule on PBMs appeared first on MedCity …